Tirzepatide 20mg

Name: Tirzepatide 20mg
SKU: 229
Availability: InStock

$79.99

Tirzepatide – Dual GIP/GLP-1 agonist peptide for glucose metabolism and weight loss research.
• 20 mg lyophilized peptide
• ≥99% purity | U.S. manufactured | Trusted by PRH

Category: Peptides

Description
Reviews (0)

Tirzepatide – 10mg | Research Peptide for Metabolic & Obesity Models | PRH

Tirzepatide 10mg research peptide – dual GIP and GLP-1 receptor agonist studied for blood sugar regulation, insulin sensitivity, and weight loss models.

Tirzepatide – 20mg

Dual GIP and GLP-1 Receptor Agonist for Advanced Metabolic Research | From Peptide Research Hub

What is Tirzepatide?

Tirzepatide is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This unique mechanism offers researchers a powerful compound for studying metabolic disorders such as type 2 diabetes, obesity, and insulin resistance.

The 20mg format provides enhanced value for laboratories conducting longitudinal studies or trials involving multiple subjects, ensuring consistent peptide availability and potency across experimental groups.

Reference: Wikipedia – Tirzepatide

Mechanism of Action

Tirzepatide exerts its effects by binding and activating both GIP and GLP-1 receptors, leading to enhanced insulin secretion, reduced glucagon levels, delayed gastric emptying, and increased satiety. These pathways support its use in research related to glucose homeostasis, body weight regulation, and appetite control.

Unlike single-target GLP-1 agonists, Tirzepatide’s dual agonism provides researchers with a more comprehensive model for investigating hormonal synergy in metabolic balance.